oa SA Pharmaceutical Journal - New drug focus

Volume 73, Issue 4
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Extracted from text ... 29 SA Pharmaceutical Journal - May 2006 DRUG INFO Tamiflu(r) - Not a substitute for influenza vaccination Approved indication Tamiflu(r) contains oseltamivir and is an antiviral agent indicated for the treatment of influenza in adults and children over the age of 1 year. It is also indicated for the prevention of influenza in adults and adolescents over the age of 13 years. Mode of action Oseltamivir is a pro-drug and a selective inhibitor of influenza virus neuraminidase enzymes. Viral neuraminidase is essential for the release of newly formed virus particles from infected cells and the spread of infectious virus. The ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error